Veea Inc. and NovaGen announce potential merger to launch an Edge AI-Powered Global Health Platform
Veea Inc. and NovaGen Group B.V. have signed a term sheet to combine operations, creating a Nasdaq-listed longevity and precision-health platform. The combined company will launch NovaGen Health Networks, integrating Veea's edge computing and cybersecurity with NovaGen's cellular reprogramming technology. GeoNova Capital commits $10 million as cornerstone investor, with the combined company valued at approximately $750 million. Initial deployments are targeted for Q4 2026.